Weber SA, Bravo TC, Garteiz MD, Carbó RR, Vega RF, Weber ÁP

Language: Spanish
References: 23
Page: 185-189
PDF size: 243.90 Kb.

ABSTRACT

Background: Gastroesophageal reflux disease is a known comorbidity among morbid obese patients, and failure of antireflux surgery is greater in these cases. Gastric bypass has been performed in patients with Gastroesophageal reflux disease and previous fundoplicature, although with high morbidity. Sleeve gastrectomy could be another option with less morbidity. Objective: Present our experience with sleeve gastrectomy in patients with previous fundoplication and morbid obesity. Material and Methods: Retrospective review of morbidly obese patients with previous fundoplication who underwent sleeve gastrectomy from June 2004 to June 2010, analyzing surgical technique, operative time, hospital stay, postoperative complications, weight reduction and postoperative gastroesophageal reflux disease symptoms. Results: Among 50 MO patients who underwent sleeve gastrectomy, four had previous fundoplication, no one had recurrent gastroesophageal reflux disease, and all had hypertension. In only one, dismanteling of the wrap was done, and in the rest fundoplication was preserved. Mean operative time was 132 minutes and average hospital stay was 3 days. The average follow-up was 32 months; average weight loss was 31.5 kg and percentage of excess weight loss 60.1%. All resolved their hypertension. No patients have reported gastroesophageal reflux disease symptoms. Conclusions: Sleeves gastrectomy could be a safer option and may not necessarily cause gastroesophageal reflux disease as has been suggested, however surgical technique may require variations, depending on the anatomic findings in each patient.

REFERENCES

1. Frezza EE, Ikramuddin S, Gourash W, Rakitt T, Kingston A, Luketich J, Schauer P. Symptomatic improvement in gastroesophageal reflux disease (GERD) following laparoscopic Roux-en-Y gastric bypass. Surg Endosc. 2002: 16: 1027–1031.

2. Perez AR, Moncure AC, Rattner DW. Obesity adversely affects the outcome of antireflux operations. Surg Endosc 2001: 15: 986–989.

3. Fraser J, Watson DI, O’Boyle CJ, Jamieson GG. Obesity and its effect on outcome of laparoscopic Nissen fundoplication. Dis Esoph. 2001; 14: 50–53.

4. Córdova-Villalobos JA. Las enfermedades crónicas no transmisibles en México. Sinopsis epidemiológica y prevención integral. Salud Pública Mex. 2008: 50; 419-427.

5. Murray L, Johnston B, Lane A et al. Relationship between body mass and gastro-oesophageal reflux symptoms: the Bristol Helieobacter Project. Int J Epidemiol. 2003; 32: 645-650.

6. Foster A, Richards WO, McDowell J et al. Gastrointestinal symptoms are more intense in morbidly obese patients. Surg Endose. 2003; 17: 1766-1768.

7. Korwar V, Peters M, Adjepong S, Sigurdsson A. Laparoscopic hiatus hernia repair and simultaneous sleeve gastrectomy: a novel approach in the treatment of gastroesophageal reflux disease associated with morbid obesity. J Laparoendosc Adv Surg Tech A. 2009; 19: 761-763.

8. Zainabadi K, Courcoulas AP, Awais O, Raftopoulos I. Laparoscopic revision of Nissen fundoplication to Roux-en-Y

9. gastric bypass in morbidly obese patients. Surg Endosc. 2008; 22: 2737-2740.

10. Buchwald H, Williams SE. Bariatric Surgery World Wide 2003. Obes Surg. 2004; 14: 1157-1164.

11. Patterson EJ, Davis DG, Khajanchee Y et al. Comparison of objective outcomes following laparoscopic Nissen fundoplication versus laparoscopic gastric bypass in the morbidly obese with heartburn. Surg Endosc. 2003; 17: 1561–1565.

12. Hess DS, Hess DW. Biliopancreatic diversion with duodenal switch. Obes Surg. 1998; 8: 267-282.

13. Braghetto I, Lanzarini E, Korn O, Valladares H, Molina JC, Henriquez A. Manometric changes of the lower esophageal sphincter after sleeve gastrectomy in obese patients. Obes Surg. 2010; 20: 357-362.

14. Chiu S, Birch DW, Shi X, Sharma AM, Karmali S. Effect of sleeve gastrectomy on gastroesophageal reflux disease: a systematic review. Surg Obes Relat Dis. 2010; 21.

15. Gagner M, Deitel M, Kalberer TL, Erickson AL, Crosby RD. The Second International Consensus Summit for Sleeve Gastrectomy. March 19-21, 2009. Surg Obes Relat Dis. 2009; 5: 476-485.

16. Raftopoulos I, Awais O, Courcoulas AP, Luketich JD. Laparoscopic gastric bypass after antireflux surgery for the treatment of gastroesophageal reflux in morbidly obese patients: initial experience. Obes Surg. 2004; 14: 1373-1380.

17. Kellogg TA, Andrade R, Maddaus M, Slusarek B, Buchwald H, Ikramuddin S. Anatomic findings and outcomes after antireflux procedures in morbidly obese patients undergoing laparoscopic conversion to Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2007; 3: 52-57.

18. Merchant AM, Cook MW, Srinivasan J, Davis SS, Sweeney JF, Lin E. Comparison between laparoscopic paraesophageal hernia repair with sleeve gastrectomy and paraesophageal hernia repair alone in morbidly obese patients. Am Surg. 2009; 75: 620-625.

19. Soricelli E, Casella G, Rizzello M, Calì B, Alessandri G, Basso N. Initial experience with laparoscopic crural closure in the management of hiatal hernia in obese patients undergoing sleeve gastrectomy. Obes Surg. 2010; 5.

20. De Csepel J, Nahouraii R, Gagner M. Laparoscopic gastric bypass as a reoperative bariatric surgery for failed open restrictive procedures. Initial experience in seven patients. Surg Endosc. 2001; 15: 393-397.

21. Houghton SG, Nelson LG, Swain JM et al. Is Roux-en-Y gastric bypass safe after previous antireflux surgery? Technical feasibility and postoperative symptom assessment. Surg Obes Relat Dis. 2005; 1: 475–480.

22. Weber, A. Bravo, C. Sleeve Gastrectomy after previous fundoplication. Oral Presentation XII 12th annual meeting of the Mexican College of Bariatric Surgery and Metabolic Diseases, Zacatecas. 2010.

23. Arvidsson D. LSG after previous fundoplication with Nissen or Toupet, how to proceed. Oral Presentation 3rd. Annual international Consensus Summit for Sleeve Gastrectomy New York. Dec, 2010.